Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Resistant Hypertension in Diabetic Patients
NCT02426099Phase 4Completed
- Start
- Oct 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in resistant hypertension (RH). Started Oct 2011; status: completed.
02
Drugs
spironolactone
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02426099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02426099.